Zhang, Ruijing
Chang, Runze
Wang, Heng
Chen, Jinshan
Lu, Chuanlong
Fan, Keyi
Zhang, Yuhang
Li, Lizheng
Yan, Sheng
Dong, Honglin
Funding for this research was provided by:
The Shanxi Provincial Government’s Regional Cooperation Program (202204041101038)
The Shanxi Provincial Government’s Regional Cooperation Program (202204041101038)
The Shanxi Provincial Government’s Regional Cooperation Program (202204041101038)
The Shanxi Provincial Government’s Regional Cooperation Program (202204041101038)
the Leading Talent Team Building Program (202204051002010)
the Leading Talent Team Building Program (202204051002010)
the Leading Talent Team Building Program (202204051002010)
the Leading Talent Team Building Program (202204051002010)
the Translational Medicine Engineering Research Center for Vascular Diseases of Shanxi Province, China (2022017)
the Translational Medicine Engineering Research Center for Vascular Diseases of Shanxi Province, China (2022017)
the Translational Medicine Engineering Research Center for Vascular Diseases of Shanxi Province, China (2022017)
the Translational Medicine Engineering Research Center for Vascular Diseases of Shanxi Province, China (2022017)
the Construction and Demonstration of Molecular Diagnosis and Treatment Platform for Vascular Diseases in Shanxi Province, China (SCP-2023-17)
the Construction and Demonstration of Molecular Diagnosis and Treatment Platform for Vascular Diseases in Shanxi Province, China (SCP-2023-17)
the Construction and Demonstration of Molecular Diagnosis and Treatment Platform for Vascular Diseases in Shanxi Province, China (SCP-2023-17)
the Construction and Demonstration of Molecular Diagnosis and Treatment Platform for Vascular Diseases in Shanxi Province, China (SCP-2023-17)
the Central Government Guidance Fund for Local Projects, China (YDZJSX2021C026)
the Central Government Guidance Fund for Local Projects, China (YDZJSX2021C026)
the Central Government Guidance Fund for Local Projects, China (YDZJSX2021C026)
the Central Government Guidance Fund for Local Projects, China (YDZJSX2021C026)
Article History
Received: 2 September 2024
Accepted: 19 November 2024
First Online: 4 February 2025
Declarations
:
: The authors declare no competing interests.
: This retrospective study involving human participants was performed in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of the Second Hospital of Shanxi Medical University ((2024)YX No. 116). All animal experiments were carried out in accordance with the institutional guidelines and were approved by the animal ethics committee of the Second Hospital of Shanxi Medical University (DW2023046).
: The authors declare that none of the work reported in this study could have been influenced by any known competing financial interests or personal relationships.